Cumberland Pharmaceuticals
Breanne Gibson, PhD, currently serves as a Senior Clinical Scientist at Cumberland Pharmaceuticals since May 2022, where responsibilities include supporting preclinical and clinical studies, preparing regulatory documents, and analyzing data for safety and efficacy assessments. Prior to this role, Breanne worked as a Clinical Research Fellow at Vanderbilt University Medical Center, conducting studies on musculoskeletal health and coordinating clinical teams. Breanne's academic background includes a PhD in Pharmacology and a Certificate in Molecular Medicine from Vanderbilt University and a Bachelor's Degree in Biology from Cedarville University. Experience also encompasses research roles at Vanderbilt University and Vanderbilt University Medical Center, focusing on various aspects of injury, coagulation, and microbial virulence factors.
This person is not in the org chart
Cumberland Pharmaceuticals
2 followers
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops and commercializes branded prescription products designed to improve quality of care and address unmet medical needs. With a focus on underserved niche markets, including hospital acute care and gastroenterology, they deliver products that serve patients in the U.S. market. Cumberland also makes its products available to patients internationally through select strategic partnerships. They own the worldwide rights to all their brands. While Cumberland’s commercial capabilities are focused on the U.S. market, their business development team is actively pursuing opportunities to make their brands available to patients in markets around the globe. Their primary mission is to improve upon patient care with products that offer clear advantages over existing treatments. They also strive to deliver solutions that may help reduce costs for healthcare providers and, ultimately, patients.